STRS Ohio’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.3M Sell
499,705
-32,917
-6% -$1.92M 0.12% 173
2025
Q4
$28.7M Sell
532,622
-46,600
-8% -$2.24M 0.11% 180
2025
Q3
$26.1M Sell
579,222
-63,631
-10% -$2.97M 0.1% 210
2025
Q2
$29.8M Buy
642,853
+47,591
+8% +$2.34M 0.11% 203
2025
Q1
$36.3M Sell
595,262
-11,891
-2% -$693K 0.15% 144
2024
Q4
$34.3M Sell
607,153
-16,287
-3% -$910K 0.14% 159
2024
Q3
$32.3M Sell
623,440
-235,243
-27% -$11M 0.12% 188
2024
Q2
$35.7M Buy
858,683
+274,226
+47% +$12.3M 0.14% 163
2024
Q1
$31.7M Sell
584,457
-64,335
-10% -$3.28M 0.13% 191
2023
Q4
$33.3M Sell
648,792
-41,079
-6% -$2.16M 0.14% 179
2023
Q3
$40M Sell
689,871
-49,769
-7% -$3.05M 0.18% 140
2023
Q2
$47.3M Sell
739,640
-47,153
-6% -$3.16M 0.2% 120
2023
Q1
$54.5M Sell
786,793
-33,720
-4% -$2.38M 0.24% 108
2022
Q4
$59M Sell
820,513
-20,559
-2% -$1.55M 0.27% 93
2022
Q3
$59.8M Sell
841,072
-323,666
-28% -$23.5M 0.28% 82
2022
Q2
$89.7M Buy
1,164,738
+24,159
+2% +$1.84M 0.4% 51
2022
Q1
$83.3M Buy
1,140,579
+419,547
+58% +$28.2M 0.3% 80
2021
Q4
$45M Sell
721,032
-56,416
-7% -$3.31M 0.16% 162
2021
Q3
$46M Sell
777,448
-79,593
-9% -$5.24M 0.17% 145
2021
Q2
$57.3M Sell
857,041
-70,032
-8% -$4.57M 0.21% 116
2021
Q1
$58.5M Sell
927,073
-177,324
-16% -$11M 0.22% 108
2020
Q4
$68.5M Sell
1,104,397
-93,829
-8% -$5.77M 0.26% 89
2020
Q3
$72.2M Sell
1,198,226
-62,069
-5% -$3.74M 0.3% 69
2020
Q2
$74.1M Sell
1,260,295
-57,675
-4% -$3.45M 0.32% 62
2020
Q1
$73.5M Sell
1,317,970
-42,251
-3% -$2.58M 0.39% 62
2019
Q4
$87.3M Buy
1,360,221
+367,525
+37% +$21M 0.37% 62
2019
Q3
$50.3M Sell
992,696
-3,518
-0.4% -$165K 0.22% 120
2019
Q2
$45.2M Buy
996,214
+4,654
+0.5% +$217K 0.2% 128
2019
Q1
$47.3M Buy
991,560
+11,839
+1% +$590K 0.21% 125
2018
Q4
$50.9M Buy
979,721
+6,771
+0.7% +$364K 0.26% 110
2018
Q3
$60.4M Sell
972,950
-76,113
-7% -$4.52M 0.26% 104
2018
Q2
$58.1M Sell
1,049,063
-343,243
-25% -$18.5M 0.25% 109
2018
Q1
$88.1M Sell
1,392,306
-39,214
-3% -$2.52M 0.39% 53
2017
Q4
$87.7M Sell
1,431,520
-98,504
-6% -$6.16M 0.37% 62
2017
Q3
$97.5M Sell
1,530,024
-195,241
-11% -$11.4M 0.42% 46
2017
Q2
$96.1M Buy
1,725,265
+128,111
+8% +$6.97M 0.43% 43
2017
Q1
$86.9M Sell
1,597,154
-54,116
-3% -$2.97M 0.38% 57
2016
Q4
$96.5M Buy
1,651,270
+23,237
+1% +$1.27M 0.43% 49
2016
Q3
$87.8M Sell
1,628,033
-37,164
-2% -$2.39M 0.39% 52
2016
Q2
$122M Buy
1,665,197
+186,698
+13% +$13.2M 0.54% 38
2016
Q1
$94.4M Buy
1,478,499
+2,234
+0.2% +$141K 0.42% 51
2015
Q4
$102M Buy
1,476,265
+169,313
+13% +$11.2M 0.45% 48
2015
Q3
$77.4M Buy
1,306,952
+5,097
+0.4% +$323K 0.37% 64
2015
Q2
$86.6M Sell
1,301,855
-10,282
-0.8% -$678K 0.38% 61
2015
Q1
$84.6M Sell
1,312,137
-21,101
-2% -$1.32M 0.37% 64
2014
Q4
$78.7M Sell
1,333,238
-53,171
-4% -$3M 0.34% 72
2014
Q3
$71M Hold
1,386,409
0.31% 80
2014
Q2
$67.3M Sell
1,386,409
-46,771
-3% -$2.3M 0.3% 93
2014
Q1
$74.5M Sell
1,433,180
-33,500
-2% -$1.78M 0.33% 73
2013
Q4
$78M Sell
1,466,680
-32,076
-2% -$1.63M 0.35% 72
2013
Q3
$69.4M Sell
1,498,756
-187,544
-11% -$8.23M 0.31% 87
2013
Q2
$75.4M Buy
+1,686,300
New +$73.2M 0.32% 72

Other funds holding BMY

STRS Ohio's BMY Position: Q1 2026 in Review

STRS Ohio reduced its Bristol-Myers Squibb (BMY) stake by 6.2% in Q1 2026, selling an estimated $1.92M and leaving 499,705 shares worth $30.3M. The position accounts for 0.12% of the portfolio, ranked #173.

STRS Ohio first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $122M in Q2 2016. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • STRS Ohio held 499,705 shares of Bristol-Myers Squibb worth $30.3M as of Q1 2026.
  • STRS Ohio sold 32,917 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.92M.
  • Bristol-Myers Squibb made up 0.12% of STRS Ohio's portfolio in Q1 2026, its #173 holding.
  • STRS Ohio first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • STRS Ohio's Bristol-Myers Squibb position peaked at $122M in Q2 2016.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.